HN2003000071A - Combinaciones de un ligando alfa-2-delta con un inhibidor selectivo de la ciclooxigenasa-2 - Google Patents

Combinaciones de un ligando alfa-2-delta con un inhibidor selectivo de la ciclooxigenasa-2

Info

Publication number
HN2003000071A
HN2003000071A HN2003000071A HN2003000071A HN2003000071A HN 2003000071 A HN2003000071 A HN 2003000071A HN 2003000071 A HN2003000071 A HN 2003000071A HN 2003000071 A HN2003000071 A HN 2003000071A HN 2003000071 A HN2003000071 A HN 2003000071A
Authority
HN
Honduras
Prior art keywords
alfa
delta
binding
combinations
cyclooxygenasa
Prior art date
Application number
HN2003000071A
Other languages
English (en)
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of HN2003000071A publication Critical patent/HN2003000071A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4245—Oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Abstract

ESTA INVENCION SE REFIERE A COMBINACIONES QUE COMPRENDEN UN INHIBIDOR SELECTIVO DE LA COX-2 Y UN LIGANDO ALFA-2- DELTA, O SUS SALES FARMACEUTICAMENTE ACEPTABLES.
HN2003000071A 2002-02-22 2003-02-21 Combinaciones de un ligando alfa-2-delta con un inhibidor selectivo de la ciclooxigenasa-2 HN2003000071A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35929502P 2002-02-22 2002-02-22
US40436502P 2002-08-19 2002-08-19

Publications (1)

Publication Number Publication Date
HN2003000071A true HN2003000071A (es) 2003-11-24

Family

ID=27760521

Family Applications (1)

Application Number Title Priority Date Filing Date
HN2003000071A HN2003000071A (es) 2002-02-22 2003-02-21 Combinaciones de un ligando alfa-2-delta con un inhibidor selectivo de la ciclooxigenasa-2

Country Status (21)

Country Link
US (1) US20030199567A1 (es)
EP (1) EP1480639A1 (es)
JP (1) JP2005523281A (es)
KR (1) KR20040085216A (es)
CN (1) CN1635887A (es)
AR (1) AR038531A1 (es)
AU (1) AU2003246864A1 (es)
BR (1) BR0307906A (es)
CA (1) CA2476438A1 (es)
CO (1) CO5611109A2 (es)
HN (1) HN2003000071A (es)
IL (1) IL162932A0 (es)
MX (1) MXPA04008175A (es)
NO (1) NO20043947L (es)
PA (1) PA8567201A1 (es)
PE (1) PE20031052A1 (es)
PL (1) PL372210A1 (es)
RU (1) RU2286151C2 (es)
TW (1) TW200303214A (es)
UY (1) UY27675A1 (es)
WO (1) WO2003070237A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2341240T3 (es) * 2002-12-13 2010-06-17 Warner-Lambert Company Llc Ligando alfa-2-delta para tratar los sintomas del tracto urinario inferior.
WO2004084881A1 (en) * 2003-03-21 2004-10-07 Dynogen Pharmaceuticals, Inc. METHODS FOR TREATING FUNCTIONAL BOWEL DISORDERS USING α2δ SUBUNIT CALCIUM CHANNEL MODULATORS WITH SMOOTH MUSCLE MODULATORS
EP1721607A1 (en) * 2003-03-21 2006-11-15 Dynogen Pharmaceuticals, Inc. Methods for treating lower urinary tract disorders using smooth muscle modulators and alpha-2-delta subunit calcium channel modulators
WO2004084880A1 (en) * 2003-03-21 2004-10-07 Dynogen Pharmaceuticals, Inc. METHODS FOR TREATING PAIN USING SMOOTH MUSCLE MODULATORS AND α2δ SUBUNIT CALCIUM CHANNEL MODULATORS
US7169812B2 (en) * 2003-07-01 2007-01-30 Medtronic, Inc. Process for producing injectable gabapentin compositions
KR100828218B1 (ko) * 2003-09-12 2008-05-07 화이자 인코포레이티드 알파-2-델타 리간드 및 세로토닌/노르아드레날린 재흡수 억제제를 포함하는 조합물
GB0322140D0 (en) * 2003-09-22 2003-10-22 Pfizer Ltd Combinations
EP1682149B1 (en) * 2003-10-23 2009-12-02 Medtronic, Inc. Injectable gabapentin compositions
TW200806627A (en) * 2006-04-11 2008-02-01 Novartis Ag Organic compounds
BRPI0718874A2 (pt) * 2006-12-22 2015-06-23 Novartis Ag Compostos orgânicos
CA2723358A1 (en) * 2008-05-05 2009-11-12 Allison B. Reiss Method for improving cardiovascular risk profile of cox inhibitors
PE20110291A1 (es) * 2008-09-05 2011-06-04 Gruenenthal Chemie Combinacion farmaceutica de 3-(3-dimetilamino-1-etil-2-metil-propil)-fenol y un antiepileptico
KR102631399B1 (ko) 2018-03-30 2024-02-01 씨지인바이츠 주식회사 폴마콕시브 및 프레가발린을 포함하는 통증 치료용 약제학적 조성물
US20220125773A1 (en) * 2020-10-28 2022-04-28 Tremeau Pharmaceuticals, Inc. Aqueous formulations of water insoluble cox-2 inhibitors

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5234929A (en) * 1992-07-20 1993-08-10 William Chelen Method of treating motion sickness with anticonvulsants and antitussive agents
US5321012A (en) * 1993-01-28 1994-06-14 Virginia Commonwealth University Medical College Inhibiting the development of tolerance to and/or dependence on a narcotic addictive substance
US5420270A (en) * 1993-10-07 1995-05-30 G. D. Searle & Co. Aryl substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
US5466823A (en) * 1993-11-30 1995-11-14 G.D. Searle & Co. Substituted pyrazolyl benzenesulfonamides
US5352638A (en) * 1994-02-22 1994-10-04 Corning Incorporated Nickel aluminosilicate glass-ceramics
US5633272A (en) * 1995-02-13 1997-05-27 Talley; John J. Substituted isoxazoles for the treatment of inflammation
AU8668598A (en) * 1997-08-20 1999-03-08 University Of Oklahoma, The Gaba analogs to prevent and treat gastrointestinal damage
ATE311867T1 (de) * 1997-09-08 2005-12-15 Warner Lambert Co Analgetische zusammensetzung enthaltend antiepileptische arzneistoffe und deren verwendungen
AU759392B2 (en) * 1997-12-16 2003-04-10 Warner-Lambert Company 4(3)substituted-4(3)-aminomethyl-(thio)pyran or -piperidine derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
US6451857B1 (en) * 1999-03-10 2002-09-17 Warner-Lambert Company Analgesic compositions comprising anti-epileptic compounds and methods of using same
HN2000000224A (es) * 1999-10-20 2001-04-11 Warner Lambert Co Aminoacidos biciclicos como agentes farmaceuticos
GB9927844D0 (en) * 1999-11-26 2000-01-26 Glaxo Group Ltd Chemical compounds
AU1930301A (en) * 1999-12-08 2001-06-18 Pharmacia Corporation Valdecoxib compositions

Also Published As

Publication number Publication date
BR0307906A (pt) 2004-12-21
MXPA04008175A (es) 2004-11-26
EP1480639A1 (en) 2004-12-01
RU2286151C2 (ru) 2006-10-27
PE20031052A1 (es) 2003-12-24
PA8567201A1 (es) 2003-11-12
RU2004125609A (ru) 2006-01-27
IL162932A0 (en) 2005-11-20
NO20043947L (no) 2004-09-21
AR038531A1 (es) 2005-01-19
CN1635887A (zh) 2005-07-06
TW200303214A (en) 2003-09-01
AU2003246864A1 (en) 2003-09-09
KR20040085216A (ko) 2004-10-07
PL372210A1 (en) 2005-07-11
UY27675A1 (es) 2003-09-30
CO5611109A2 (es) 2006-02-28
US20030199567A1 (en) 2003-10-23
CA2476438A1 (en) 2003-08-28
WO2003070237A1 (en) 2003-08-28
JP2005523281A (ja) 2005-08-04

Similar Documents

Publication Publication Date Title
HN2003000227A (es) Inhibidores de quinasas
ECSP055888A (es) Derivados de aril-quinazolin/aril-2-amino-fenil metanona que promueven la liberación de la hormona paratiroides.
HN2003000071A (es) Combinaciones de un ligando alfa-2-delta con un inhibidor selectivo de la ciclooxigenasa-2
HN2006019066A (es) "(s)-n-metilnaltrexona"
DK1572670T3 (da) 5-substitueret-pyrazin eller -pyridin-glucokinaseaktivatorer
PA8624601A1 (es) Macrolidos y metodos para producir los mismos
DE602004007730D1 (de) Niedrig gekohlter Automatenstahl.
NL1024881A1 (nl) PPAR-activatoren.
NO20041432L (no) Sammensetninger som innbefatter COX-2 inhibitorer og aspirin.
ATE417560T1 (de) Chirurgischer nagel
DE60328884D1 (de) Wabenbildungshülse
ES1052291Y (es) Pieza para acera modular y acera modular que la incorpora.
ATE333010T1 (de) Sanitärkabine
BR0314427A (pt) Usos de pirimetanil
ITTO20030655A1 (it) Freno o frizi0ne innestabile.
BR0317312B8 (pt) adaptador.
ES1052367Y (es) Martillo de emergencia de facil localizacion.
ITTO20020161A1 (it) Scuola di scarpe chiodate.
HN2002000084A (es) Fenil - heterociclil - eteres
ES1053239Y (es) Pieza constructiva prefabricada.
DE60232650D1 (de) Peptiddeformylaseinhibitoren
HN2002000351A (es) 1,3-diarilprop-2-en-1-onas, composiciones que las contienen y sus utilizacion
ES1052613Y (es) Martillo para la aplicacion de marchamos.
ES1052320Y (es) Colgante para llavero.
HN2000000168A (es) Gen de striptomyces avermitilis que dirigen la relacion de avermectinas b2:b1